NCT04814914
Completed
Not Applicable
An Observational Study to Evaluate the Presence of Symptoms After COVID-19 Infection in Patients Who Participated in K031-120 or K032-120 Study ("Long Hauler")
Kaleido Biosciences2 sites in 1 country333 target enrollmentMarch 25, 2021
ConditionsCOVID-19
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- COVID-19
- Sponsor
- Kaleido Biosciences
- Enrollment
- 333
- Locations
- 2
- Primary Endpoint
- Proportion of patients with persistent COVID-19 symptoms for at least 12-weeks post-randomization in K031-120 or K032-120 study.
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
This observational clinical study aims to evaluate the presence of symptoms of COVID-19 infection in patients who participated in K031-120 or K032-120 ("long hauler").
Investigators
Eligibility Criteria
Inclusion Criteria
- •Have consented to participate over the telephone
- •Have been randomized in either the K031-120 or K032-120 study
Exclusion Criteria
- •Have withdrawn consent from K031-120 or K032-120
Outcomes
Primary Outcomes
Proportion of patients with persistent COVID-19 symptoms for at least 12-weeks post-randomization in K031-120 or K032-120 study.
Time Frame: 12-weeks from randomization in K031-120 or K032-120
Study Sites (2)
Loading locations...
Similar Trials
Withdrawn
Not Applicable
Coronavirus-19 (COVID-19) and Related Outcomes in School Aged Children (ABC Health Outcomes in Children)Covid19; MIS-CNCT04757831Duke University
Completed
Not Applicable
An Observational Study of Patients With Coronavirus Disease 2019COVID-19CoronavirusNCT04331886Target PharmaSolutions, Inc.199
Completed
Not Applicable
Clinical Course and Treatment of COVID-19 Inpatients in HospitalCOVID-19NCT04527497Wissenschaftliches Institut Bethanien e.V35
Unknown
Not Applicable
An Observational Study in Patients With Mild to Moderate COVID-19COVID-19NCT05366244Shanghai Pudong Hospital100
Recruiting
Not Applicable
Prospective observational study of COVID-19 patients in the TOKUSHUKAI GROUPThe purpose of this study is to collect information of the clinical course of patients with COVID-19 treated at Tokushukai hospitals with and without antiviral drugs and to explore the clinical course in the acute phase, the frequency of severe disease, and frequency of post COVID-19 condition by the treatment, after adjusting by patient background including risk factor(s) and symptoms at the time of registration.JPRN-UMIN000053506Shionogi & Co., Ltd.30,000